Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jul 2026 for Werewolf Therapeutics, Inc., €29k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
MPM BioVentures 2014, L.P.: trading record in brief
All filings by MPM BioVentures 2014, L.P. on record concern Werewolf Therapeutics, Inc. In total, 2 filings cover trades dated from 29 June 2026 to 6 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 July 2026 came the latest disclosure, a transaction for €29k in Werewolf Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to MPM BioVentures 2014, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
96,873 shares@ US$0.34040.068% mcap3.8% of flowCommonSEC144:0001628280-26-047360
106,262 shares@ US$0.3230.071% mcap4.0% of flowCommonSEC144:0001628280-26-046082
2 of 2 declarations
